Amarin reported $364.74M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amarin AMRN:US $ 364.74M 5.69M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
AstraZeneca AZN:LN 23649M 1427M
Epizyme EPZM:US $ 44.74M 3.84M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
GlaxoSmithKline GSK:LN 22417M 1030M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NOVN:VX SF 29880M 247M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M